Bristol-Myers Squibb
BMY
2,461 hedge funds and large institutions have $88.5B invested in Bristol-Myers Squibb in 2025 Q4 according to their latest regulatory filings, with 378 funds opening new positions, 875 increasing their positions, 957 reducing their positions, and 146 closing their positions.
159% more first-time investments, than exits
New positions opened: 378 | Existing positions closed: 146
55% more funds holding in top 10
Funds holding in top 10: 20 → 31 (+11)
24% more capital invested
Capital invested by funds: $71.6B → $88.5B (+$16.9B)
8% more funds holding
Funds holding: 2,276 → 2,461 (+185)
2.62% more ownership
Funds ownership: 78.01% → 80.63% (+2.6%)
9% less repeat investments, than reductions
Existing positions increased: 875 | Existing positions reduced: 957
30% less call options, than puts
Call options by funds: $1.33B | Put options by funds: $1.91B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$786M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$448M |
| 3 |
Bank of New York Mellon
New York
|
+$377M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$293M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$199M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$548M |
| 2 |
JP Morgan Chase
New York
|
-$520M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$492M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$273M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$217M |
BMY Hedge Fund Activity: Q4 2025 in Review
2,461 of the 8,284 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q4 2025, worth a combined $88.5B — up 24% from $71.6B a quarter earlier.
Buyers outnumbered sellers: 378 funds opened new BMY positions and 146 closed out — a net gain of 232 holders — while 875 added to existing stakes and 957 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $786M. The largest seller was Capital International Investors, cutting an estimated $548M.
- 2,461 institutional investors held Bristol-Myers Squibb (BMY) as of Q4 2025, up from 2,276 in Q3 2025.
- Funds reported $88.5B of Bristol-Myers Squibb stock for Q4 2025, up 24% quarter-over-quarter.
- 378 funds opened new Bristol-Myers Squibb positions in Q4 2025 and 146 closed out, a net change of +232 holders.
- The largest Bristol-Myers Squibb buyer in Q4 2025 was AQR Capital Management, an estimated $786M added.
- The largest Bristol-Myers Squibb seller in Q4 2025 was Capital International Investors, an estimated $548M sold.
Based on aggregated 13F filings for Q4 2025.